Laryngorhinootologie 2024; 103(S 02): S158
DOI: 10.1055/s-0044-1784494
Abstracts │ DGHNOKHC
Aerodigestive tract/Laryngology/Phoniatrics: Phoniatrics

Treatment of vocal fold Nodules: Transnasal steroid injection versus Microlaryngoscopic Phonomicrosurgery

Asser Elsaeed
1   Mansoura University, Unit of Phoniatrics, ORL department, Faculty of medicine, Mansoura
,
Omayma Afsah
1   Mansoura University, Unit of Phoniatrics, ORL department, Faculty of medicine, Mansoura
,
Tadeus Nawka
2   Charité - Universitätsmedizin Berlin, Abteilung für Audiologie und Phoniatrie, Berlin
,
Philipp Caffier
2   Charité - Universitätsmedizin Berlin, Abteilung für Audiologie und Phoniatrie, Berlin
,
Hemmat Baz
1   Mansoura University, Unit of Phoniatrics, ORL department, Faculty of medicine, Mansoura
› Author Affiliations
 
 

    Objectives The aim of the present study was to compare treatment outcomes of vocal fold steroid injection (VFSI) and surgery in patients with vocal fold (VFNs) in terms of lesion regression, subjective, and objective voice parameters.

    Methods This bicenter interventional study was conducted on 32 patients with VFNs, in the age range of 16−63 years. Sixteen patients underwent transnasal VFSI under local anesthesia (the injection group), and 16 underwent surgical excision of the nodules under general anesthesia (the surgery group). Prior to intervention and at the follow-up visit, participants were subjected to videolaryngoscopic examination with evaluation of nodules" sizes as well as subjective voice assessment by auditory perceptual assessment (APA) of voice and the international nine-item Voice Handicap Index (VHI-9i). Objective voice assessments including the measurements of cepstral peak prominence, jitter, shimmer, harmonic to noise ratio, and maximum phonation time were also administered.

    Results The size of vocal fold nodules was significantly decreased postintervention in both studied groups. There was a decrease in the VHI-9i score, a decrease in the values of jitter and shimmer, together with an increase in the values of cepstral peak prominence and maximum phonation time after interventions indicating improvement of subjective and objective voice outcomes in both groups.

    Conclusion Office-based transnasal VFSI is a safe and tolerable therapy option for VFNs. Voice outcomes of VFSI were comparable to surgery, hereby VFSI can be considered a promising therapy for VFNs and could be used as an alternative to surgery in selected cases.


    Publication History

    Article published online:
    19 April 2024

    © 2024. Thieme. All rights reserved.

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany